| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 153.50 | 14113 |
| Intrinsic value (DCF) | 0.37 | -66 |
| Graham-Dodd Method | n/a | |
| Graham Formula | n/a |
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.